Comparing the protective effects of ciprofloxacin, moxifloxacin and levofloxacin in mice with lipopolysaccharide‐induced acute lung injuries

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Respirology (Carlton South. Print)

• Publication date

  2008-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1440-1843.2007.01192.xPMID 18197910
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.

  2008cited by this paper
• THE EFFECT OF CIPROFLOXACIN ON CD14 AND TOLL-LIKE RECEPTOR-4 EXPRESSION ON HUMAN MONOCYTES

  2006cited by this paper
• Moxifloxacin inhibits cytokine-induced MAP kinase and NF-kappaB activation as well as nitric oxide synthesis in a human respiratory epithelial cell line.

  2005cited by this paper
• Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?

  2005cited by this paper
• Immunomodulatory effects of antimicrobials in the therapy of respiratory tract infections

  2005cited by this paper
• Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome

  2004cited by this paper
• The effects of macrolides on inflammatory cells.

  2004cited by this paper
• Immunomodulatory effects of quinolones.

  2003cited by this paper
• Effect of moxifloxacin on secretion of cytokines by human monocytes stimulated with lipopolysaccharide.

  2002cited by this paper
• Effect of ciprofloxacin on lethal and sublethal challenge with endotoxin and on early cytokine responses in a murine in vivo model.

  2002cited by this paper
• Immunomodulatory and Protective Effects of Moxifloxacin against Candida albicans-Induced Bronchopneumonia in Mice Injected with Cyclophosphamide

  2002cited by this paper
• Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention.

  2001cited by this paper
• Regulation of chemokine expression by IL-10 in lung inflammation.

  2000cited by this paper
• Differential effects of nitric oxide synthase inhibitors in an in vivo allergic rat model.

  2000cited by this paper
• Protection against Lipopolysaccharide-Induced Death by Fluoroquinolones

  2000cited by this paper
• The effect of three broad-spectrum antimicrobials on mononuclear cell responses to encapsulated bacteria: evidence for down-regulation of cytokine mRNA transcription by trovafloxacin.

  2000cited by this paper
• Macrophage Inflammatory Protein-2 Predicts Acute Lung Injury in Endotoxemia

  1998cited by this paper
• Acute lung injury in the medical ICU: comorbid conditions, age, etiology, and hospital outcome.

  1998cited by this paper
• The effect of antimicrobial agents on the induction of tumour necrosis factor by alveolar macrophages in vitro in response to endotoxin.

  1997cited by this paper
• Biological markers of acute lung injury: prognostic and pathogenetic significance.

  1997cited by this paper
• Enhanced hematopoiesis in sublethally irradiated mice treated with various quinolones

  1997cited by this paper
• Immunomodulatory action of levofloxacin on cytokine production by human peripheral blood mononuclear cells.

  1996cited by this paper
• Intra-alveolar macrophage-inflammatory peptide 2 induces rapid neutrophil localization in the lung.

  1996cited by this paper
• TNFα and increased chemokine expression in rat lung after particle exposure

  1995cited by this paper
• Identification of patients with acute lung injury. Predictors of mortality.

  1995cited by this paper
• TNF alpha and increased chemokine expression in rat lung after particle exposure.

  1995cited by this paper
• Increased interleukin 2 transcription in murine lymphocytes by ciprofloxacin.

  1994cited by this paper
• Antitumor quinolones with mammalian topoisomerase II mediated DNA cleavage activity.

  1992cited by this paper
• A multicenter registry of patients with acute respiratory distress syndrome. Physiology and outcome.

  1992cited by this paper
• Ciprofloxacin treatment in vivo increases the ex vivo capacity of lipopolysaccharide‐stimulated human monocytes to produce IL‐1, IL‐6 and tumour necrosis factor‐alpha

  1991cited by this paper
• Ciprofloxacin enhances T cell function by modulating interleukin activities

  1991cited by this paper
• Immunological aspects of new quinolones

  1991cited by this paper
• Differential regulation of IL 6, IL 1 A, IL 1 beta and TNF alpha production in LPS-stimulated human monocytes: role of cyclic AMP.

  1990cited by this paper
• Differential regulation of IL 6, IL 1 A, IL 1β and TNFα production in LPS-stimulated human monocytes: Role of cyclic AMP

  1990cited by this paper
• Intratracheal instillation method for mouse lungs.

  1973cited by this paper

• Immunomodulatory Effects of Fluoroquinolones in Community-Acquired Pneumonia-Associated Acute Respiratory Distress Syndrome

  2024influential citation
• The tale of antibiotics beyond antimicrobials: Expanding horizons.

  2023cites this paper
• Dual functional therapeutics: mitigating bacterial infection and associated inflammation.

  2023cites this paper
• Small molecules targeting endolysosomal acidification and signaling in sepsis and severe SARS-CoV-2 infection/COVID-19

  2022cites this paper
• Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19

  2021cites this paper
• Antibiotics as immunomodulators: a potential pharmacologic approach for ARDS treatment

  2021cites this paper
• Nemonoxacin Has Immunoprotective Effects on Reducing Mortality in Lipopolysaccharide-Induced Mouse Sepsis Model

  2020cites this paper
• Concentration-Dependent Dual Effects of Ciprofloxacin on SB-590885-Resistant BRAFV600E A375 Melanoma Cells.

  2019cites this paper
• Oxidative stress effect of levofloxacin on broilers

  2019cites this paper
• Long-term oral antibiotic treatment : why, what, when and to whom?

  2017cites this paper
• Spectroscopic studies and thermal analysis of mononuclear metal complexes with moxifloxacin and 2,2′-bipyridine and their effects on acute lung injury induced by hydrochloric acid in rats

  2017cites this paper
• New Inducible Nitric Oxide Synthase and Cyclooxygenase-2 Inhibitors, Nalidixic Acid Linked to Isatin Schiff Bases via Certain l-Amino Acid Bridges

  2016cites this paper
• Potent Antiedematous and Protective Effects of Ciprofloxacin in Pulmonary Ricinosis

  2016cites this paper
• Acid aspiration provokes the pneumonia caused by multidrug-resistant Acinetobacter baumannii in BALB/c mice.

  2013cites this paper
• Ameliorating Effects of Moxifloxacin on Endotoxin-Induced Acute Lung Injury in Rats

  2011cites this paper
• Characterisation of a refined rat model of respiratory infection with Pseudomonas aeruginosa and the effect of ciprofloxacin.

  2011cites this paper
• Moxifloxacin Alleviates Oleic Acid-provoked Neutrophilic Respiratory Burst in the Rat Lung through the Inhibition of Cytosolic Phospholipase A2

  2010cites this paper
• In vivo efficacy of sivelestat in combination with pazufloxacin against Legionella pneumonia

  2010cites this paper
• Ventilator Induced Lung Injury. Pathophysiology of mechanotransduction and therapeutic strategies.

  2009cites this paper
• Influence of type and neutralisation capacity of antacids on dissolution rate of ciprofloxacin and moxifloxacin from tablets.

  2009cites this paper
• Immunomodulation in the critically ill

  2009cites this paper
• Respirology year‐in‐review 2008: Basic science

  2009cites this paper
• Low-tidal-volume Mechanical Ventilation Induces a Toll-like Receptor 4–dependent Inflammatory Response in Healthy Mice

  2008cites this paper